Medical Health Technology — October 2, 2026

Technology Overview

Medicine is changing faster than at any point in a generation. AI now reads scans and drafts clinical notes, gene and cell therapies are winning approval, and data platforms are reshaping how care is delivered and paid for. Medical health technology covers the devices, diagnostics, therapeutics, software and research infrastructure behind that shift, and the companies here span it end to end. Global drugmakers such as Merck and Sanofi are advancing targeted oncology and immunology pipelines. MedTech manufacturers such as Philips, Medtronic and Boston Scientific supply imaging, monitoring and interventional systems. Integrated health systems and academic medical centers turn research into patient care.

The ecosystem extends well beyond them. It includes AI diagnostics firms, genomics and liquid biopsy developers, contract research and manufacturing organizations, EHR and revenue-cycle software vendors, and digital mental health platforms. Regulators, funders such as ARPA-H and NIH, regional biotech clusters, and specialist investors are shaping where capital and innovation flow next.

Current Products and News

• Merck & Co, Inc. (MDS) signed an exclusive global license with SciBrunch Therapeutics for SPR2015, an investigational oral KRAS G12D inhibitor, on September 28, 2026. Three days earlier, the FDA approved WELIREG plus LENVIMA for certain previously treated adults with advanced clear cell renal cell carcinoma.
• Stanford Medicine had two teams win ARPA-H contracts on September 30, 2026 to use AI to improve patient outcomes. This followed a $25 million grant to create an AI-focused center for dementia treatments.
• Food and Drug Administration approved the first heart valve designed to grow with children on October 1, 2026. It also approved the first gene therapy for pediatric Sanfilippo Syndrome Type A on September 17.
• Sanofi announced an expanded global alliance with Regeneron on October 1, 2026, covering multiple next-generation, long-acting immunology antibodies.
• Axogen, Inc. completed its acquisition of BioCircuit Technologies on October 1, 2026. The deal adds NerveTape, described as the first FDA-cleared device for sutureless peripheral nerve repair, and follows a $208.7 million public offering.
• Grail Inc won a favorable FDA Advisory Committee vote on September 23, 2026 for its Galleri multi-cancer early detection blood test.
• Abridge Al, Inc was selected on September 22, 2026 to bring ambient AI to veteran care nationwide through the VA Enterprise Contract.
• Fresenius Kabi AG completed its acquisition of the remaining 45% of mAbxience on October 1, 2026, taking full ownership of the biosimilars platform.

10 Leading Companies

1. Scripps Health: A San Diego integrated not-for-profit health system with specialized cancer, heart and transplant centers, which recently secured a new multi-year Anthem Blue Cross agreement and national recognition for its oncology program.
2. Columbia University Medical Center (CUMC): A New York academic medical center with NIH-funded research spanning cancer, neuroscience and AI, including recent work on combination therapy for metastatic pancreatic cancer.
3. Stanford University School of Medicine: An R1 research institution with centers for AI in medicine, digital health and cancer, and a steady flow of ARPA-H contracts, major grants and open-source research tools.
4. Advent Health: One of the largest US health systems, with 22 hospitals named Vizient 2026 Top Performers and ongoing expansion through new sites and partnerships.
5. Merck & Co, Inc. (MDS): A top global pharmaceutical company by revenue and market capitalization, with fresh FDA approvals, a KRAS inhibitor licensing deal and positive late-stage trial readouts.
6. Philips Medical Systems: A self-described global MedTech leader in imaging, monitoring and AI-driven diagnostics, recently selected for an ARPA-H stroke-care program and launching new ultrasound and interventional MR solutions.
7. Memorial Sloan-Kettering Cancer Institute (MSK): A globally renowned oncology center combining patient care, research and training across surgery, immunotherapy and targeted therapy.
8. NYU Langone Medical Center: A New York academic health system named the No. 1 health system by Vizient for the fifth consecutive year, which is also applying AI to radiology training.
9. Sanofi: A Paris-based global biopharmaceutical major spanning specialty care, vaccines and consumer health, with an expanded Regeneron immunology alliance and new partnerships.
10. Food and Drug Administration: The US regulator whose device and drug decisions shape the market, with recent first-of-a-kind approvals and new programs such as an expedited IND pilot.

Get Ahead in Medical Health Technology

This market moves every day. On October 2, 2026 alone, 912 companies in this ebook updated their newsrooms. Computer Review puts all 5,100 companies across 73 countries in one place, with 3,003 job pages tracked, so you see the moves as they happen.

With a subscription you can:

• Catch every press release the day it is published
• Know who leads each company and who is hiring
• Size up markets country by country
• Find any company or topic in seconds with keyword search

Start today for just $15 a month, cancel any time, or get the best value at $120 a year and save 33%.

Start your subscription →